Role of cyclic AMP in the eye with glaucoma

키워드

참고문헌 (158)

1. Weinreb RN, "Primary open-angle glaucoma", Lancet, 363, pp.1711~1720 (2004)
2. Zhang K, "Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma", Nat Rev Drug Discov, 11, pp.541~559 (2012)
3. Weinreb RN, "Primary open-angle glaucoma", Nat Rev Dis Primers, 2, pp.16067~ (2016)
4. Rall TW, "Formation of a cyclic adenine ribonucleotide by tissue particles", J Biol Chem, 232, pp.1065~1076 (1958)
5. Huneycutt BS, "Regulation of astrocyte cell biology by the cAMP", protein kinase A signaling pathway, 1995, pp.5, 261~269
6. Ladilov Y, "Role of soluble adenylyl cyclase in cell death and growth", Biochim Biophys Acta, 1842, pp.2646~2655 (2014)
7. Martinez J, "Soluble adenylyl cyclase is necessary and sufficient to overcome the block of axonal growth by myelinassociated factors", J Neurosci, 34, pp.9281~9289 (2014)
8. Insel PA, "Cyclic AMP is both a pro-apoptotic and anti-apoptotic second messenger", Acta Physiol (Oxf), 204, pp.277~287 (2012)
9. Walsh DA, "An adenosine 3', 5'-monophosphate-dependant protein kinase from rabbit skeletal muscle", J Biol Chem, 243, pp.3763~3765 (1968)
10. Taylor SS, "PKA: lessons learned after twenty years", Biochim Biophys Acta, 1834, pp.1271~1278 (2013)
11. de Rooij J, "Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP", Nature, 396, pp.474~477 (1998)
12. Kawasaki H, "A family of cAMP-binding proteins that directly activate Rap1", Science (New York, N.Y.), 282, pp.2275~2279 (1998)
13. Kaupp UB, "Cyclic nucleotide-gated ion channels", Physiol Rev, 82, pp.769~824 (2002)
14. Matulef K, "Cyclic nucleotidegated ion channels", Annu Rev Cell Dev Biol, 19, pp.23~44 (2003)
15. Sunahara RK, "Complexity and diversity of mammalian adenylyl cyclases", Annu Rev Pharmacol Toxicol, 36, pp.461~480 (1996)
16. Patel TB, "Molecular biological approaches to unravel adenylyl cyclase signaling and function", Gene, 269, pp.13~25 (2001)
17. Buck J, "Cytosolic adenylyl cyclase defines a unique signaling molecule in mammals", Proc Natl Acad Sci U S A, 96, pp.79~84 (1999)
18. Hanoune J, "Regulation and role of adenylyl cyclase isoforms", Annu Rev Pharmacol Toxicol, 41, pp.145~174 (2001)
19. Defer N, "Tissue specificity and physiological relevance of various isoforms of adenylyl cyclase", Am J Physiol Renal Physiol, 279, pp.F400~F416 (2000)
20. Tang WJ, "Adenylyl cyclases", Cell, 70, pp.869~872 (1992)
21. Cooper DM, "Regulation and organization of adenylyl cyclases and cAMP", Biochem J, 375, pp.517~529 (2003)
22. Valsecchi F, "cAMP and mitochondria", Physiology (Bethesda, Md.), 28, pp.199~209 (2013)
23. Pierre S, "Capturing adenylyl cyclases as potential drug targets", Nat Rev Drug Discov, 8, pp.321~335 (2009)
24. Lee YS, "Soluble adenylyl cyclase in the eye", Biochim Biophys Acta, 1842, pp.2579~2583 (2014)
25. Caprioli J, "Forskolin lowers intraocular pressure in rabbits, monkeys, and man", Lancet, 1, pp.958~960 (1983)
26. Burstein NL, "Aqueous flow in human eyes is reduced by forskolin, a potent adenylate cyclase activator", Exp Eye Res, 39, pp.745~749 (1984)
27. Majeed M, "Efficacy and safety of 1% forskolin eye drops in open angle glaucoma-An open label study", Saudi J Ophthalmol, 29, pp.197~200 (2015)
28. Weinreb RN, "The pathophysiology and treatment of glaucoma: a review", JAMA, 311, pp.1901~1911 (2014)
29. Corredor RG, "Soluble adenylyl cyclase activity is necessary for retinal ganglion cell survival and axon growth", J Neurosci, 32, pp.7734~7744 (2012)
30. Hellstrom M, "Cyclic AMP and the regeneration of retinal ganglion cell axons", Int J Biochem Cell Biol, 56, pp.66~73 (2014)
31. Cueva Vargas JL, "The glial cell modulator ibudilast attenuates neuroinflammation and enhances retinal ganglion cell viability in glaucoma through protein kinase A signaling", Neurobiol Dis, 93, pp.156~171 (2016)
32. de Lima S, "Combinatorial therapy stimulates long-distance regeneration, target reinnervation, and partial recovery of vision after optic nerve injury in mice", Int Rev Neurobiol, 106, pp.153~172 (2012)
33. Tamm ER, "The trabecular meshwork outflow pathways: structural and functional aspects", Exp Eye Res, 88, pp.648~655 (2009)
34. Alm A, "Uveoscleral outflow--a review", Exp Eye Res, 88, pp.760~768 (2009)
35. Crowston JG, "Glaucoma medication and aqueous humor dynamics", Curr Opin Ophthalmol, 16, pp.94~100 (2005)
36. Grant WM, "Physiological and pharmacological influences upon intraocular pressure", Pharmacol Rev, 7, pp.143~182 (1955)
37. Lee PF, "The influence of epinephrine and phenylephrine on intraocular pressure", AMA Arch Ophthalmol, 60, pp.863~867 (1958)
38. Ericson LA, "Twenty-four hourly variations in the inflow of the aqueous humour", Acta Ophthalmol (Copenh), 36, pp.30~ (1958)
39. Neufeld AH, "Cyclic- AMP in the aqueous humor: the effects of adrenergic agents", Exp Eye Res, 14, pp.242~250 (1972)
40. Realini T, "A history of glaucoma pharmacology", Optom Vis Sci, 88, pp.36~38 (2011)
41. Katz IM, "Intraocular pressure decrease in normal volunteers following timolol ophthalmic solution", Invest Ophthalmol, 15, pp.489~492 (1976)
42. Zimmerman TJ, "The betaadrenergic blocking agents and the treatment of glaucoma", Surv Ophthalmol, 23, pp.347~362 (1979)
43. Neufeld AH, "In vitro determination of the ability of drugs to bind to adrenergic receptors", Invest Ophthalmol Vis Sci, 16, pp.1118~1124 (1977)
44. Bromberg BB, "Betaadrenergic receptors in ciliary processes of the rabbit", Invest Ophthalmol Vis Sci, 19, pp.203~207 (1980)
45. Nathanson JA, "Adrenergic regulation of intraocular pressure: identification of beta 2-adrenergic-stimulated adenylate cyclase in ciliary process epithelium", Proc Natl Acad Sci U S A, 77, pp.7420~7424 (1980)
46. Caprioli J, "The adenylate cyclase receptor complex and aqueous humor formation", Yale J Biol Med, 57, pp.283~300 (1984)
47. Eakins KE, "Adrenergic mechanisms and the outflow of aqueous humor from the rabbit eye", J Pharmacol Exp Ther, 144, pp.60~65 (1964)
48. Neufeld AH, "Cyclic-AMP in ocular tissues of the rabbit, monkey, and human", Invest Ophthalmol, 13, pp.475~477 (1974)
49. Gregory D, "Intraocular pressure and aqueous flow are decreased by cholera toxin", Invest Ophthalmol Vis Sci, 20, pp.371~381 (1981)
50. Ross RA, "Effects of topically applied isoproterenol on aqueous dynamics in man", Arch Ophthalmol, 83, pp.39~46 (1970)
51. Sears M, "A major pathway for the regulation of intraocular pressure", Int Ophthalmol, 6, pp.201~212 (1983)
52. Arthur S, "Update on the role of alpha-agonists in glaucoma management", Exp Eye Res, 93, pp.271~283 (2011)
53. Gharagozloo NZ, "Aqueous flow is reduced by the alpha-adrenergic agonist, apraclonidine hydrochloride(ALO 2145)", Ophthalmology, 95, pp.1217~1220 (1988)
54. Toris CB, "Effects of brimonidine on aqueous humor dynamics in human eyes", Arch Ophthalmol, 113, pp.1514~1517 (1995)
55. Bausher LP, "Regulation of cyclic AMP production in adult human ciliary processes", Exp Eye Res, 60, pp.43~48 (1995)
56. Nathanson JA, "Human ciliary process adrenergic receptor: pharmacological characterization", Invest Ophthalmol Vis Sci, 21, pp.798~804 (1981)
57. Chen S, "Role of cyclic AMP-induced Cl conductance in aqueous humour formation by the dog ciliary epithelium", Br J Pharmacol, 112, pp.1137~1145 (1994)
58. Do CW, "Basis of chloride transport in ciliary epithelium", J Membr Biol, 200, pp.1~13 (2004)
59. Gabelt BT, "Changes in aqueous humor dynamics with age and glaucoma", Prog Retin Eye Res, 24, pp.612~637 (2005)
60. Toris CB, "Aqueous humor dynamics in the aging human eye", Am J Ophthalmol, 127, pp.407~412 (1999)
61. Neufeld AH, "Adenosine 3', 5'-monophosphate increases the outflow of aqueous humor from the rabbit eye", Invest Ophthalmol, 14, pp.40~42 (1975)
62. Neufeld AH, "Adenosine 3', 5'-monophosphate analogue increases the outflow facility of the primate eye", Invest Ophthalmol, 14, pp.688~689 (1975)
63. Pfeiffer N, "Dorzolamide: development and clinical application of a topical carbonic anhydrase inhibitor", Surv Ophthalmol, 42, pp.137~151 (1997)
64. Mittag TW, "Bicarbonateactivated adenylyl cyclase in fluid-transporting tissues", Am J Physiol, 264, pp.F1060~F1064 (1993)
65. Lee YS, "Regulation of anterior chamber drainage by bicarbonate-sensitive soluble adenylyl cyclase in the ciliary body", J Biol Chem, 286, pp.41353~41358 (2011)
66. Hiett JA, "Topical carbonic anhydrase inhibitors: a new perspective in glaucoma therapy", Optom Clin, 2, pp.97~112 (1992)
67. Shahidullah M, "Nonpigmented ciliary epithelial cells respond to acetazolamide by a soluble adenylyl cyclase mechanism", Invest Ophthalmol Vis Sci, 55, pp.187~197 (2014)
68. Lee YS, "Control of outflow resistance by soluble adenylyl cyclase", J Ocul Pharmacol Ther, 30, pp.138~142 (2014)
69. Yu K, "Bestrophin-2 mediates bicarbonate transport by goblet cells in mouse colon", J Clin Invest, 120, pp.1722~1735 (2010)
70. Zhang Y, "Bestrophin 2 is expressed in human non-pigmented ciliary epithelium but not retinal pigment epithelium", Mol Vis, 16, pp.200~206 (2010)
71. Bakall B, "Bestrophin-2 is involved in the generation of intraocular pressure", Invest Ophthalmol Vis Sci, 49, pp.1563~1570 (2008)
72. Zhang Y, "Enhanced inflow and outflow rates despite lower IOP in bestrophin-2-deficient mice", Invest Ophthalmol Vis Sci, 50, pp.765~770 (2009)
73. Chen Y, "Soluble adenylyl cyclase as an evolutionarily conserved bicarbonate sensor", Science, 289, pp.625~628 (2000)
74. Donegan RK, "Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions", J Med Chem, 59, pp.788~809 (2016)
75. Migdal C, "Glaucoma medical treatment: philosophy, principles and practice", Eye, 14, pp.515~518 (2000)
76. Medeiros FA, "Medical backgrounders: glaucoma", Drugs Today (Barc), 38, pp.563~570 (2002)
77. Mitchelson F, "Muscarinic receptor agonists and antagonists: effects on ocular function", Handb Exp Pharmacol, 208, pp.263~298 (2012)
78. Zhang X, "Expression of adenylate cyclase subtypes II and IV in the human outflow pathway", Invest Ophthalmol Vis Sci, 41, pp.998~1005 (2000)
79. Cracknell KP, "Prostaglandin analogues in the anterior eye: their pressure lowering action and side effects", Exp Eye Res, 88, pp.786~791 (2009)
80. Prasanna G, "Pharmacology of novel intraocular pressure-lowering targets that enhance conventional outflow facility: Pitfalls, promises and what lies ahead?", Eur J Pharmacol, 787, pp.47~56 (2016)
81. Inda C, "Different cAMP sources are critically involved in G protein-coupled receptor CRHR1 signaling", J Cell Biol, 214, pp.181~195 (2016)
82. Shen S, "Retinal ganglion cells lose trophic responsiveness after axotomy", Neuron, 23, pp.285~295 (1999)
83. Goldberg JL, "Retinal ganglion cells do not extend axons by default: promotion by neurotrophic signaling and electrical activity", Neuron, 33, pp.689~702 (2002)
84. Russo R, "Intravitreal injection of forskolin, homotaurine, and L-carnosine affords neuroprotection to retinal ganglion cells following retinal ischemic injury", Mol Vis, 21, pp.718~729 (2015)
85. Rehen SK, "Contrasting effects of protein synthesis inhibition and of cyclic AMP on apoptosis in the developing retina", Development, 122, pp.1439~1448 (1996)
86. Meyer-Franke A, "Depolarization and cAMP elevation rapidly recruit TrkB to the plasma membrane of CNS neurons", Neuron, 21, pp.681~693 (1998)
87. Shaw PX, "Soluble Adenylyl Cyclase Is Required for Retinal Ganglion Cell and Photoreceptor Differentiation", Invest Ophthalmol Vis Sci, 57, pp.5083~5092 (2016)
88. Lucas DR, "The toxic effect of sodium L-glutamate on the inner layers of the retina", AMA Arch Ophthalmol, 58, pp.193~201 (1957)
89. Olney JW, "Brain damage in infant mice following oral intake of glutamate, aspartate or cysteine", Nature, 227, pp.609~611 (1970)
90. Olney JW, "Glutaate-induced retinal degeneration in neonatal mice. Electron microscopy of the acutely evolving lesion", J Neuropathol Exp Neurol, 28, pp.455~474 (1969)
91. Lipton SA, "Possible role for memantine in protecting retinal ganglion cells from glaucomatous damage", Surv Ophthalmol, 48(Suppl 1), pp.S38~S46 (2003)
92. Dong CJ, "Alpha2 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity", Invest Ophthalmol Vis Sci, 49, pp.4515~4522 (2008)
93. Gao H, "Up-regulation of brain-derived neurotrophic factor expression by brimonidine in rat retinal ganglion cells", Arch Ophthalmol, 120, pp.797~803 (2002)
94. Dong CJ, "Alpha2 adrenergic receptor-mediated modulation of cytosolic Ca＋＋ signals at the inner plexiform layer of the rat retina", Invest Ophthalmol Vis Sci, 48, pp.1410~1415 (2007)
95. Maier C, "Neuroprotection by the alpha 2-adrenoreceptor agonist dexmedetomidine in a focal model of cerebral ischemia", Anesthesiology, 79, pp.306~312 (1993)
96. Matsuo T, "Localization of alpha-2 adrenergic receptors in the human eye", Ophthalmic Res, 24, pp.213~219 (1992)
97. Wheeler LA, "Role of alpha-2 adrenergic receptors in neuroprotection and glaucoma", Surv Ophthalmol, 45(Suppl 3), pp.S290~S294 (2001)
98. Woldemussie E, "Localization of alpha 2 receptors in ocular tissues", Vis Neurosci, 24, pp.745~756 (2007)
99. Kalapesi FB, "Human ganglion cells express the alpha-2 adrenergic receptor: relevance to neuroprotection", Br J Ophthalmol, 89, pp.758~763 (2005)
100. Evans DW, "Contrast sensitivity improves after brimonidine therapy in primary open angle glaucoma: a case for neuroprotection", Br J Ophthalmol, 87, pp.1463~1465 (2003)
101. Krupin T, "A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study", Am J Ophthalmol, 151, pp.671~681 (2011)
102. Goldenberg-Cohen N, "Possible neuroprotective effect of brimonidine in a mouse model of ischaemic optic neuropathy", Clin Exp Ophthalmol, 37, pp.718~729 (2009)
103. Lee KY, "Brimonidine is neuroprotective against glutamateinduced neurotoxicity, oxidative stress, and hypoxia in purified rat retinal ganglion cells", Mol Vis, 16, pp.246~251 (2010)
104. Lambert WS, "Brimonidine prevents axonal and somatic degeneration of retinal ganglion cell neurons", Mol Neurodegener, 6, pp.4~ (2011)
105. Lee D, "Brimonidine blocks glutamate excitotoxicity-induced oxidative stress and preserves mitochondrial transcription factor a in ischemic retinal injury", PLoS One, 7, pp.e47098~ (2012)
106. Donello JE, "alpha(2)-Adrenoceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemia", J Pharmacol Exp Ther, 296, pp.216~223 (2001)
107. i increase in salamander retinal ganglion cells: modulation by PKA and adrenergic receptors, "Vis Neurosci", 2002, 249~256
108. Miotke JA, "Immunohistochemical localization of CNTFRalpha in adult mouse retina and optic nerve following intraorbital nerve crush: evidence for the axonal loss of a trophic factor receptor after injury", J Comp Neurol, 500, pp.384~400 (2007)
109. Dunn TA, "Calciumdependent increases in protein kinase-A activity in mouse retinal ganglion cells are mediated by multiple adenylate cyclases", PLoS One, 4, pp.e7877~ (2009)
110. Dunn TA, "Imaging of cAMP levels and protein kinase A activity reveals that retinal waves drive oscillations in second-messenger cascades", J Neurosci, 26, pp.12807~12815 (2006)
111. Park YH, "AMPA receptor desensitization is the determinant of AMPA receptor mediated excitotoxicity in purified retinal ganglion cells", Exp Eye Res, 132, pp.136~150 (2015)
112. Nicol X, "Role of the calcium modulated cyclases in the development of the retinal projections", Eur J Neurosci, 24, pp.3401~3414 (2006)
113. Sunahara RK, "Isoforms of mammalian adenylyl cyclase: multiplicities of signaling", Mol Interv, 2, pp.168~184 (2002)
114. Jonas JB, "Morphometry of the human lamina cribrosa surface", Invest Ophthalmol Vis Sci, 32, pp.401~405 (1991)
115. Schneider M, "The role of astrocytes in optic nerve head fibrosis in glaucoma", Exp Eye Res, 142, pp.49~55 (2016)
116. Hernandez MR, "Astrocytes in glaucomatous optic neuropathy", Prog Brain Res, 173, pp.353~373 (2008)
117. Hernandez MR, "The optic nerve head in glaucoma: role of astrocytes in tissue remodeling", Prog Retin Eye Res, 19, pp.297~321 (2000)
118. Anderson DR, "Ultrastructure of human and monkey lamina cribrosa and optic nerve head", Arch Ophthalmol, 82, pp.800~814 (1969)
119. Varela HJ, "Astrocyte responses in human optic nerve head with primary open-angle glaucoma", J Glaucoma, 6, pp.303~313 (1997)
120. Lukas TJ, "Susceptibility to glaucoma: differential comparison of the astrocyte transcriptome from glaucomatous African American and Caucasian American donors", Genome Biol, 9, pp.R111~ (2008)
121. Chen L, "Hydrostatic pressure-dependent changes in cyclic AMP signaling in optic nerve head astrocytes from Caucasian and African American donors", Mol Vis, 15, pp.1664~1672 (2009)
122. Ju WK, "Increased mitochondrial fission and volume density by blocking glutamate excitotoxicity protect glaucomatous optic nerve head astrocytes", Glia, 63, pp.736~753 (2015)
123. Son JL, "Glaucomatous optic nerve injury involves early astrocyte reactivity and late oligodendrocyte loss", Glia, 58, pp.780~789 (2010)
124. Sun D, "Structural remodeling of fibrous astrocytes after axonal injury", J Neurosci, 30, pp.14008~14019 (2010)
125. Dai C, "Structural basis of glaucoma: the fortified astrocytes of the optic nerve head are the target of raised intraocular pressure", Glia, 60, pp.13~28 (2012)
126. Leske MC, "Open-angle glaucoma--an epidemiologic overview", Ophthalmic Epidemiol, 14, pp.166~172 (2007)
127. Miao H, "Gene expression and functional studies of the optic nerve head astrocyte transcriptome from normal African Americans and Caucasian Americans donors", PLoS One, 3, pp.e2847~ (2008)
128. Trimmer PA, "Immunocytochemically defined astroglia from fetal, newborn and young adult rats express beta-adrenergic receptors in vitro", Brain Res, 392, pp.151~165 (1986)
129. Salm AK, "Norepinephrineevoked calcium transients in cultured cerebral type 1 astroglia", Glia, 3, pp.529~538 (1990)
130. Mantyh PW, "Beta 2-adrenergic receptors are expressed by glia in vivo in the normal and injured central nervous system in the rat, rabbit, and human", J Neurosci, 15, pp.152~164 (1995)
131. Small KM, "An Ile to Met polymorphism in the catalytic domain of adenylyl cyclase type 9 confers reduced beta2-adrenergic receptor stimulation", Pharmacogenetics, 13, pp.535~541 (2003)
132. Lopez-Canales OA, "Role of adenylyl cyclase in reduced beta-adrenoceptormediated vasorelaxation during maturation", Braz J Med Biol Res, 49, pp.e5285~ (2016)
133. Sato PY, "The evolving impact of g protein-coupled receptor kinases in cardiac health and disease", Physiol Rev, 95, pp.377~404 (2015)
134. Peppel K, "G protein-coupled receptor kinase 3 (GRK3) gene disruption leads to loss of odorant receptor desensitization", J Biol Chem, 272, pp.25425~25428 (1997)
135. Yamamoto S, "Defects in the rhodopsin kinase gene in the Oguchi form of stationary night blindness", Nature Genet, 15, pp.175~178 (1997)
136. De Vries L, "The regulator of G protein signaling family", Annu Rev Pharmacol Toxicol, 40, pp.235~271 (2000)
137. Wang Q, "Receptor-selective effects of endogenous RGS3 and RGS5 to regulate mitogen-activated protein kinase activation in rat vascular smooth muscle cells", J Biol Chem, 277, pp.24949~24958 (2002)
138. Tezel G, "Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences", Prog Retin Eye Res, 25, pp.490~513 (2006)
139. Beal MF, "Aging, energy, and oxidative stress in neurodegenerative diseases", Ann Neurol, 38, pp.357~366 (1995)
140. Jenner P, "Oxidative stress as a cause of Parkinson's disease", Acta Neurol Scand Suppl, 136, pp.6~15 (1991)
141. Coyle JT, "Oxidative stress, glutamate, and neurodegenerative disorders", Science, 262, pp.689~695 (1993)
142. Dringen R, "Peroxide detoxification by brain cells", J Neurosci Res, 79, pp.157~165 (2005)
143. Fernandez-Fernandez S, "Antioxidant and bioenergetic coupling between neurons and astrocytes", Biochem J, 443, pp.3~11 (2012)
144. Noh YH, "Inhibition of oxidative stress by coenzyme Q10 increases mitochondrial mass and improves bioenergetic function in optic nerve head astrocytes", Cell Death Dis, 4, pp.e820~ (2013)
145. Lee D, "Coenzyme Q10 inhibits glutamate excitotoxicity and oxidative stressmediated mitochondrial alteration in a mouse model of glaucoma", Invest Ophthalmol Vis Sci, 55, pp.993~1005 (2014)
146. Lee D, "Coenzyme Q10 ameliorates oxidative stress and prevents mitochondrial alteration in ischemic retinal injury", Apoptosis, 19, pp.603~614 (2014)
147. Kim SY, "Inhibition of cyclophilin D by cyclosporin A promotes retinal ganglion cell survival by preventing mitochondrial alteration in ischemic injury", Cell Death Dis, 5, pp.e1105~ (2014)
148. Yan L, "Type 5 adenylyl cyclase disruption increases longevity and protects against stress", Cell, 130, pp.247~258 (2007)
149. Ogura M, "Upregulation of the glutamine transporter through transactivation mediated by cAMP", protein kinase A signals toward exacerbation of vulnerability to oxidative stress in rat neocortical astrocytes, 2007, pp.212, 375~385
150. Ciccarelli R, "Molecular signalling mediating the protective effect of A1 adenosine and mGlu3 metabotropic glutamate receptor activation against apoptosis by oxygen", glucose deprivation in cultured astrocytes, 2007, pp.71, 1369~1380
151. Durand D, "Reduced cAMP, Akt activation and p65-c-Rel dimerization: mechanisms involved in the protective effects of mGluR3 agonists in cultured astrocytes", PLoS One, 6, pp.e22235~ (2011)
152. Seifert R, "Functional selectivity of G-proteincoupled receptors: from recombinant systems to native human cells", Biochem Pharmacol, 86, pp.853~861 (2013)
153. Berstein G, "Reconstitution of agonist-stimulated phosphatidylinositol 4,5- bisphosphate hydrolysis using purified m1 muscarinic receptor, Gq", 11, and phospholipase C-beta 1, 1992, pp.267, 8081~8088
154. Buck MA, "Muscarinic acetylcholine receptor subtypes which selectively couple to phospholipase C: pharmacological and biochemical properties", Biochem Biophys Res Commun, 173, pp.666~672 (1990)
155. Burford NT, "Muscarinic m1 receptor-stimulated adenylate cyclase activity in Chinese hamster ovary cells is mediated by Gs alpha and is not a consequence of phosphoinositidase C activation", Biochem J, 315, pp.883~888 (1996)
156. Qin K, "Inactivestate preassembly of G(q)-coupled receptors and G(q)heterotrimers", Nat Chem Biol, 7, pp.740~747 (2011)
157. Jones SV, "Functional responses of cloned muscarinic receptors expressed in CHO-K1 cells", Mol Pharmacol, 40, pp.242~247 (1991)
158. Caulfield MP, "Muscarinic receptors--characterization, coupling and function", Pharmacol Ther, 58, pp.319~379 (1993)

관련 논문AI추천